Thyroid function depends on processing of the prohormone thyroglobulin by sequential proteolytic events. From in vitro analysis it is known that cysteine proteinases mediate proteolytic processing of thyroglobulin. Here, we have analyzed mice with deficiencies in cathepsins B, K, L, B and K, or K and L in order to investigate which of the cysteine proteinases is most important for proteolytic processing of thyroglobulin in vivo. Immunolabeling demonstrated a rearrangement of the endocytic system and a redistribution of extracellularly located enzymes in thyroids of cathepsin-deficient mice. Cathepsin L was upregulated in thyroids of cathepsin K -/-or B -/-/K -/-mice, suggesting a compensation of cathepsin L for cathepsin K deficiency. Impaired proteolysis resulted in the persistence of thyroglobulin in the thyroids of mice with deficiencies in cathepsin B or L. The typical multilayered appearance of extracellularly stored thyroglobulin was retained in cathepsin K -/-mice only. These results suggest that cathepsins B and L are involved in the solubilization of thyroglobulin from its covalently cross-linked storage form. Cathepsin K -/-/L -/-mice had significantly reduced levels of free thyroxine, indicating that utilization of luminal thyroglobulin for thyroxine liberation is mediated by a combinatory action of cathepsins K and L.
affected by various mutations resulting in the expression of nonfunctional enzyme (17) .
Homozygous mice with a deficiency in cathepsin L are fertile but develop periodic hair loss due to alterations of hair follicle morphogenesis and cycling (18, 19) . Cathepsin L-deficient mice develop cardiac alterations that closely resemble human dilated cardiomyopathy (20) . Furthermore, cathepsin L is essential for degradation of invariant chain during MHC class II-restricted antigen presentation in cortical thymic epithelial cells (21) .
Mice with double deficiencies in cathepsins B and L were recently reported to suffer from an early-onset postnatal brain atrophy, and to die during the second to fourth week of life (22) . In our hands, mice with double deficiencies in cathepsins B and L were also lethal in a very early postnatal state, whereas those with deficiencies in cathepsins B and K, or K and L survived (our unpublished observations). Cathepsin B -/-/K -/-mice did not show an overt phenotype, whereas cathepsin K -/-/L -/-mice were smaller in size as compared with WT littermates. This growth defect of cathepsin K -/-/L -/-mice might be due in part to the osteopetrotic phenotype caused by the deficiency in cathepsin K. However, thyroid hormones have long been known as important regulators of vertebrate development and growth. Hence, if cathepsin K is indeed important for the liberation of thyroid hormones (2, 8) , the smaller stature of cathepsin K -/-/L -/-mice might additionally result from a thyroid phenotype.
To test this hypothesis in vivo, and to determine which cysteine proteinase is important for T 4 liberation from its prohormone Tg, here, we have analyzed thyroid morphology and function in cathepsin-deficient mice; i.e., cathepsin B -/-, K -/-, or L -/-mice were used. Because it could not be excluded that an overlapping function of the various enzymes is needed for proteolysis of Tg, double-deficient animals, i.e., cathepsin B -/-/K -/-or cathepsin K -/-/L -/-mice, were included in the analysis of the biological significance of cathepsins for thyroid physiology. The results demonstrate that cathepsin K -/-/L -/-mice show a significant reduction of serum T 4 levels, indicating that both cathepsins K and L are necessary for thyroid hormone liberation from Tg in mice. In addition, the typical multilayered appearance of the storage form of the prohormone Tg in the lumen of thyroid follicles was retained in cathepsin K -/-mice only, and increased amounts of Tg persisted in mice with deficiencies in cathepsin B or L. These results suggest that cathepsins B and L are most important for the solubilization step that precedes liberation of T 4 from Tg. Hence, our results support the notion that cathepsins B, K, and L have an important impact on proper function of the mouse thyroid.
Methods

Generation of mice with deficiencies in cysteine proteinases.
Cathepsin-deficient mice were generated by targeted disruption of the ctsb, ctsk, or ctsl gene. The detailed procedures have been described for the generation of cathepsin B -/- (13, 14) , cathepsin K -/- (16) , and cathepsin L -/-mice (18) .
For generation of double-deficient mice, null mutant cathepsin B, K, or L mice on a mixed 129Ola:C57BL/6J background were intercrossed. Double-heterozygous mice were identified by PCR and bred to produce double-deficient mice and controls. Double-deficient mice were identified by PCR and Southern and Western blotting as described (13, 16, 18) . All genotypes were obtained with the expected mendelian frequencies.
The animals used in all studies were maintained and bred according to institutional guidelines in the animal facilities of the University Medical Center (Freiburg, Germany) and of the University of Göttingen (Göttin-gen, Germany). All subsequent preparations, including blood sample collection and serum and tissue preparations, were performed in accordance with the same guidelines and after prior approval by the institutional animal care committees at the Universities of Bonn, Freiburg, and Göttingen (Germany).
Blood sample collection and quantitation of serum T 4 levels. For the determination of serum T 4 levels, mice were anesthetized, and blood samples were taken at 10 am by puncturing of the blood lacuna of the orbital sinus or the tail vein, or by heart puncturing. Blood samples were allowed to clot for 30-60 minutes at 37°C, and, after incubation overnight at 4°C, clotted material was carefully removed. Sera were cleared by centrifugation at 10,000 g for 10 minutes at 4°C, and stored at -20°C. For the quantitative determination of serum levels of free T 4 (FT 4 ), serum samples were analyzed in duplicates using an immunoradiometric assay according to the manufacturer's protocol (DYNOtest FT 4 ; Brahms Diagnostica GmbH, Henningsdorf/Berlin, Germany). Determination of serum FT 4 concentrations used the IRMA program of an LB 2111 gamma counter (Berthold Australia Pty Ltd., Bundoora, Victoria, Australia).
Preparation of thyroid tissue. For analysis of morphological signs of alterations in cathepsin-deficient mice, the following genotypes were used: WT mice (+/+), 12 months old, one female and two males; cathepsin B -/-mice, 8-9 months old, two females and one male; cathepsin K -/-mice, 11-12 months old, one female and two males; cathepsin L -/-mice, 10.5-12 months old, one female and two males; cathepsin B -/-/K -/-mice, 7 months old, one female and one male, and 4 months old, one female; cathepsin K -/-/L -/-mice, 9 months old, three females. Mice were anesthetized and bled by opening of the aorta descendens. Prewarmed PBS supplemented with 10 IU/ml heparin (B. Braun Melsungen AG, Melsungen, Germany) followed by 3% paraformaldehyde in PBS was perfused via the heart. Thyroid glands were dissected and freed of connective tissue. For analysis of protein expression levels, thyroid glands were excised after bleeding and perfusion with heparinized PBS.
Preparation of cryosections and immunolabeling. Dissected thyroid glands were postfixed with 8% paraformaldehyde in 200 mM HEPES at pH 7.4. After washing, thyroids were infiltrated with polyvinyl-pyrrolidone-10 in phosphate-buffered sucrose (SigmaAldrich Chemie GmbH, Taufkirchen, Germany) as cryoprotectant, and frozen in liquid propane. Sections were prepared with a cryotome (Reichert-Jung, Wien, Austria) at -60°C, and mounted on microscope slides. Blocking was performed with 3% BSA for 60 minutes at 37°C. Incubation with specific antibodies diluted in 0.1% BSA in calcium-and magnesium-free PBS occurred overnight at 4°C in a moisturized chamber. Specific antibodies were sheep anti-human cathepsin B (RD Laboratorien für Biologische Forschung GmbH, Diessen, Germany), rabbit anti-human cathepsin D (Calbiochem-Novabiochem GmbH, Bad Soden, Germany), rabbit anti-mouse cathepsin K (kindly provided by T. Kamiya, Y. Kobayashi, and H. Sakai, Nagasaki University School of Dentistry, Nagasaki, Japan) (23), rabbit anti-rat cathepsin L (kindly provided by John S. Mort, Shriners Hospital for Children, McGill University, Montreal, Quebec, Canada), rabbit anti-T 4 (ICN Biomedicals GmbH, Eschwege, Germany), rabbit anti-triiodothyronine (anti-T 3 ; ICN Biomedicals GmbH), or rabbit anti-bovine Tg (24) . Secondary antibodies were incubated for 60 minutes at 37°C. As secondary antibodies, carbocyanine (Cy2) or indocarbocyanine (Cy3) coupled to goat anti-rabbit IgG, and TRITC coupled to donkey anti-sheep F(ab) 2 fragments (Dianova, Hamburg, Germany) were used. For negative controls, specific antibodies were omitted, or cryosections of thyroids from mice with deficiencies in cathepsins B, K, and/or L were used. Cryosections were mounted in a mixture of 33% glycerol and 14% mowiol in 200 mM Tris (pH 8.5) supplemented with 5% 1,4-diazabicyclo(2.2.2)octan as antifading agent.
Microscopy, documentation, and morphometric analysis of cryosections. Cryosections were viewed with an inverted confocal laser scanning microscope (LSM 510; Carl Zeiss, Oberkochen, Germany) equipped with an argon and a helium/neon mixed-gas laser with excitation wavelengths of 488 or 543 nm. Scans at a resolution of 1024 × 1024 pixels were taken in the line-averaging mode, and at a pinhole setting of one airy unit. Micrographs were stored in LSM or TIFF format (Zeiss LSM Image Browser version 2.30.011; Carl Zeiss Jena GmbH, Jena, Germany). Color coding and image analysis were by Image-Pro Plus 4.0 software (Media Cybernetics Inc., Silver Springs, Maryland, USA). The diameters of cathepsin D-positive vesicles were determined by automatic detection of bright objects from arbitrarily chosen immunofluorescence micrographs. For the determination of epithelial extensions, i.e., the heights of thyroid epithelial cells, micrographs of cryosections of thyroids of WT and of all cathepsindeficient genotypes were analyzed by the LSM software (LSM 510 software version 2.8 SP1; Carl Zeiss, Oberkochen, Germany). Cross-sectioned follicles were arbitrarily chosen, and the areas and perimeters of each thyroid follicle and of their luminal contents were measured manually. Because most follicles are oval in shape, the value of mean epithelial extension of a given follicle was calculated using Microsoft Excel 2000 software (Microsoft Corp., Redmond, Washington, USA) according to equation 1.
Equation 1
Preparation of thyroid lysates, SDS-PAGE, immunoblotting, and densitometry. Dissected thyroids were homogenized and lysed on ice with 0.2% Triton X-100 in PBS supplemented with protease inhibitors [0.2 µg/ml aprotinin, 10 µM trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E64), 2 mM EDTA, and 1 µM pepstatin] for 30 minutes. After clearing by centrifugation at 10,000 g for 10 minutes at 4°C, the supernatants were used as thyroid lysates. Protein content was determined with Pierce Coomassie Protein Assay (Perbio Science Deutschland GmbH, Bonn, Germany) (25, 26) . Lysates were normalized to equal amounts of protein, and boiled in sample buffer consisting of 10 mM Tris-HCl (pH 7.6), 0.5% (wt/vol) SDS, 25 mM DTT, 10% (wt/vol) glycerol, and 25 µg/ml bromophenol blue. As molecular mass markers, prestained precision protein standards were used (Bio-Rad Laboratories Inc., Hercules, California, USA). Proteins were separated by SDS-PAGE (27) , blotted onto nitrocellulose, and detected by immunolabeling of the blots after blocking with 6% (wt/vol) casein, 1% (wt/vol) polyvinylpyrrolidone-40, and 10 mM EDTA in PBS plus 0.3% Tween-20. Specific antibodies were as described above for immunolabelings of cryosections, and, in addition, sheep antihuman cathepsin L (RD Laboratorien für Biologische Forschung GmbH) was used. Secondary antibodies were HRP-or peroxidase-conjugated donkey anti-sheep IgG (BIOZOL Diagnostica Vertrieb GmbH, Eching, Germany) or goat anti-rabbit IgG (Dianova). Immunoreactions were visualized by enhanced chemiluminescence onto Hyperfilm MP (Amersham Pharmacia Biotech UK Ltd., Little Chalfont, United Kingdom). Films from three to four different blots for each immunodetection were scanned (Desk Scan II version 2.9; Hewlett-Packard Co., Palo Alto, California, USA) and evaluated densitometrically by TINA version 2.09d (raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany).
Statistic evaluations. Mean values and levels of significance were calculated by one-way ANOVA (Origin 5.0 and 7.0; OriginLab Corp., Northampton, Massachusetts, USA).
Results
In the thyroid, cysteine proteinases like cathepsins B, K, and L are not restricted to lysosomes of epithelial cells; rather, they are also detected at extracellular locations, i.e., they are associated with the apical plasma membrane, and secreted into the lumen of thyroid follicles (7) (8) (9) (10) . In vitro, cathepsins were shown to cleave Tg at neutral pH conditions, leading to the direct liberation of T 4 . We concluded that the cathepsins might be involved 
Confocal fluorescence micrographs of cryosections of thyroid glands from WT mice (a) or cathepsin-deficient mice of the indicated genotypes (b-f) were immunolabeled with antibodies against cathepsin B. Thyroids from cathepsin B-deficient mice were not stained (b and e), indicating specificity of antibody labeling. Cathepsin B was detected within endocytic vesicles of thyroid epithelial cells (arrows). In WT mice, cathepsin B was also located at the apical plasma membrane of epithelial cells (arrowheads, inset) and within the lumina of thyroid follicles (asterisks). Deficiencies in cathepsin K and/or cathepsin L resulted in a redistribution of cell surface-associated cathepsin B, since immunolabelings of the apical plasma membranes were no longer observed. Rather, immunofluorescence became detectable over the follicle lumina (asterisks), and it was enhanced when compared with the (Figure 3d , inset, arrows). Accordingly, alterations in the ultrastructure of lysosomes were observed in keratinocytes and cardiomyocytes of cathepsin L-deficient mice (19, 20) .
The results of immunolocalization of lysosomal enzymes indicated that deficiencies in cysteine proteinases in thyroid epithelial cells led to an extensive rearrangement of the endocytic system, and to a redistribution of extracellularly located enzymes.
Alterations of cathepsin levels in the thyroid. Because of the altered morphology of the endocytic system of thyroid epithelial cells from cathepsin-deficient mice, we thought to investigate potential compensatory effects on the translational level. For the analysis of the levels of cathepsin expression, lysates of thyroids from mice of the indicated genotypes were normalized to equal amounts of protein, separated on SDS gels, and transferred to nitrocellulose.
Probing of the blots with antibodies against cathepsin B showed, as expected, the lack of its expression in thyroids from cathepsin B -/-or B -/-/K -/-mice (Figure 4a ). Levels of cathepsin B expression in thy-
mice were comparable to those in WT thyroids (Figure 4a ). The mature forms of cathepsin B were expressed, i.e., single chain and smaller amounts of the heavy chain of two-chain cathepsin B were detected in immunoblots (Figure 4a) .
Because it is known that cathepsin D might also be involved in Tg processing (11, 28) , and because cathepsin D-positive lysosomes were enlarged in some genotypes (see Figure 3) , the expression pattern of this aspartic protease was included in the analysis. In contrast to the principal expression of mature cathepsin B, immunoblotting of cathepsin D demonstrated that the expression of its proform dominated (Figure 4b When immunoblots were probed with various antibodies against cathepsin K purified from mouse or human tissues, or against the recombinant enzyme, or against distinct peptide regions of cathepsin K, it became obvious that the antibodies hardly recognized cathepsin K in lysates of mouse thyroids (not shown). However, several of the antibodies tested for immunoblotting indeed cross-reacted with cathepsin K of formaldehyde-fixed mouse thyroid tissue after immunolabeling of cryosections (compare Figure 2 , a-c) -and did so in a specific manner, since immunolabeling was not observed in thyroids from cathepsin T 4 liberation is mediated by cathepsins K and L. Because the endocytic system and the levels of protease expression of thyroid epithelial cells showed alterations in cathepsin-deficient mice, we postulated that Tg processing and Tg utilization, i.e., thyroid hormone liberation, might be affected.
Epithelia of thyroids from mice of all cathepsin-deficient genotypes were less extended than those of WTs (Figure 6a ), indicating that flattening of thyroid epithelia was a result of cysteine proteinase deficiency. In euthyroid vertebrates, a demand of thyroid hormones is signaled by a rise in thyroid-stimulating hormone (TSH) levels in the blood as a result of negative feedback regulation (for reviews, see refs. 29, 30) . Under such conditions of acute TSH stimulation, thyroid epithelial cells change from a cubic to a prismatic appearance, which reflects enhanced activity of thyrocytes, i.e., enhanced Tg turnover. Hence, flattening of epithelia might indicate a reduction in thyroid functional activity.
Because T 4 is the major hormone released from the thyroid (29) and becomes converted into its biologically active form T 3 by deiodinases upon entry of target cells, we considered serum T 4 levels as a relevant systemic marker of thyroid function. In general, T 4 levels were high in young animals and dropped with increasing age of WT or cathepsin B -/-or K -/-mice (Figure 6c , black, red, and green, respectively). An exception from this downregulation of T 4 levels with aging were mice with double deficiencies in cathepsins B and K, in which T 4 levels increased from significantly reduced levels in young mice to slightly elevated levels in mice older than 8 months (Figure 6c, orange) . In cathepsin L -/-or K -/-/L -/-mice, the decline of serum T 4 with age was less well pronounced as compared with WTs ( Figure 6c , blue and cyan, respectively), indicating that cathepsin L -/-or K -/-/L -/-mice developed reduced T 4 levels at an early age. The serum levels of FT4 were significantly reduced (P < 0.05) in the sera of mice with cathepsin L deficiency. In mice with double deficiency in cathepsins K and L (Figure 6d ), the reduction was even greater (P< 0.01). reduced in mice with double deficiency in cathepsins K and L (Figure 6d ). The systemic defect in thyroid function, i.e., reduction in serum T 4 , was established in both sexes of cathepsin K -/-/L -/-mice.
Reduced levels of thyroid hormones normally result in an increase in TSH levels, which may, after long intervals of several weeks, induce an enlargement of thyroid follicles due to hyperproliferation of thyroid epithelial cells. Therefore, the dimensions of thyroid follicles were analyzed morphometrically in mice with cathepsin deficiencies. In all cathepsin-deficient genotypes, an enlargement of thyroid follicles was observed when compared with the WTs (Figure 6b) . The highest values of follicle areas were observed in cathepsin B -/-thyroids (Figure 6b ), which were also characterized by extremely flat epithelia (Figure 6a ) and by the highest amounts of Tg (see below). In mice with double deficiencies in cathepsins K and L, thyroid follicle areas were enhanced by about 80% as compared with the WTs (Figure 6b) . Hence, the systemic defect in serum T 4 Figure  6b , K -/-/L -/-), a phenotype reminiscent of hypothyroidism. Deficiencies in cathepsin B, K, or L alone or in cathepsins B and K were not sufficient to induce this phenotype, indicating that a combinatory action of both cathepsins K and L is necessary for proper hormone liberation from the thyroid. Phenotypic alterations with the development of signs of hypothyroidism were observed in the mice with double deficiencies for cathepsins K and L only at the level of thyroid follicles, whereas the volumes or wet weights of thyroids from cathepsin K -/-/L -/-mice were unaltered compared with the WTs (not shown). This is most probably explained by enhanced cell death induced by cathepsin L deficiency (see above, Figure 5 ).
in cathepsin K -/-/L -/-mice (Figure 6d, K -/-/L -/-) correlated with an enlargement of thyroid follicles (
The results demonstrate that thyroid function is impaired by a deficiency in cysteine proteinases. An obvious phenotype with significantly reduced serum T 4 levels was observed in cathepsin K -/-/L -/-double-deficient mice, indicating that a combinatory action of cathepsins K and L is necessary for T 4 liberation, i.e., utilization of Tg.
Alterations in luminal Tg depositions are caused by deficiency in cathepsin B or L. Because reduced levels of serum T 4 in cathepsin K -/-/L -/-mice are most probably caused by an impaired Tg degradation, the molecular status of Tg (Figure 7) and its localization ( Figure 8 ) were analyzed next.
Equal amounts of protein of thyroid lysates from mice of the indicated genotypes were loaded onto SDS gels, and blots were probed with antibodies against Tg (Figure 7, a and b) . Protein bands representing
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The Densitometry of the gels demonstrated that the amounts of total Tg were higher in thyroids from mice of all cathepsin-deficient genotypes when compared with the WTs (Figure  7d ). Comparable results were obtained when single bands representing intact Tg or its degradation fragments were analyzed by densitometry (Figure 7c ). Fiveto sixfold higher amounts of Tg were observed in thy-
mice, whereas cathepsin K deficiency alone resulted in Tg levels that were increased only about twofold over those of the WTs (Figure 7d ), indicating that cathepsins B and L are more important than cathepsin K for the gross degradation of Tg. Because Tg degradation is not restricted to intracellular locations like lysosomes but begins with its extracellular solubilization from the covalently cross-linked storage form, an alteration of Tg degradation might also affect its luminal and/or lysosomal depositions. Therefore, cryosections from thyroids were immunolabeled with antibodies against Tg (Figure 8 ). Within thyroid epithelial cells of all cathepsin-deficient genotypes, numerous reticular and vesicular structures were immunolabeled with Tg antibodies (Figure 8 , insets, arrows). Such structures resemble cisternae of the endoplasmic reticulum as well as exo-and endocytic vesicles, indicating that Tg synthesis, export, and uptake generally occur in thyroid epithelial cells of all cathepsin-deficient genotypes. Additionally, immunofluorescence signals were often observed in association with the basal lamina surrounding individual thyroid follicles ( Figure  8 , insets, arrowheads), which are most probably representative of Tg reaching the circulation by transcytosis.
Luminal Tg showed the typical multilayered appearance within thyroid follicles of WT controls (Figure 8a) . Storage of Tg within follicle lumina occurs in a highly compacted form in which Tg is multimerized and covalently cross-linked. Hence, antibodies are less able to interact with highly compacted Tg in the center of thyroid follicle lumina, resulting in dim fluorescence intensities. In contrast, the luminal portions apposed to the apical plasma membrane are characterized by intense immunofluorescence, i.e., soluble Tg is easily accessible for the antibodies (Figure 8a, broken arrows) . Tg depositions within the lumina of thyroid follicles of cathepsin K-deficient mice (Figure 8c The absence of multilayers of luminal Tg might also explain the observation of increased thyroid follicle dimensions in cathepsin B -/-mice, which could not be explained as a result of reduced serum T 4 levels. If the rate of Tg export into the follicle lumen is unaltered, but the rate of removal of luminal Tg is reduced, then, as a consequence, the size of the luminal content must increase, resulting in an expansion of thyroid follicles. This is most clearly seen in cathepsin B -/-thyroid follicles (see B -/-in Figures 6, a and b; 7d; and 8b) . A similar phenomenon is observed in cathepsin B -/-/K -/-thyroids but might be less pronounced when compared with the cathepsin B -/-genotype, because cathepsin L expression was upregulated in cathepsin B -/-/K -/-mice (Figure 4c ) but not in cathepsin B -/-mice. These observations suggest a partial compensation of the double deficiency in cathepsins B and K by cathepsin L overexpression. Because systemic defects, i.e., significantly reduced serum levels of T 4 , were observed in cathepsin K -/-/L -/-mice only, the utilization of luminal Tg for T 4 liberation is most probably mediated by a combinatory action of cathepsins K and L. The proposed sequential steps of proteolytic degradation of Tg for its solubilization and utilization are outlined in Figure 9 .
Discussion
Our current model of the molecular mechanisms governing thyroid function is mostly derived from in vitro studies of the degradation of the prohormone Tg. Here, we have used mice with deficiencies in the cysteine proteinases cathepsins B, K, and L, which are known to be Tg-degrading enzymes. Cathepsin K -/-/L -/-mice were characterized by significantly reduced serum T 4 levels, clearly indicating that, in vivo, the utilization of Tg, i.e., the liberation of T 4 from its prohormone, is facilitated by the combinatory action of cathepsins K and L. In addition, the absence of multilayers of luminal Tg in cathepsin B -/-, L -/-, B -/-/K -/-, and K -/-/L -/-mice demonstrated that the occurrence of differentially compacted luminal Tg is dependent on the presence of cathepsins B and/or L in mouse thyroid. Hence, our results provide evidence for the notion that the cysteine proteinases cathepsins B, K, and L are important for sequential steps in the complex sequence of proteolytic events leading to the degradation of Tg in vivo (Figure 9) .
Solubilization of luminal Tg depends on expression of cathepsins B and L.
The maintenance of thyroid function is based on the bidirectional secretion and recapture pathway of Tg (for review, see ref.
1). Newly synthesized Tg is transported along the secretory route to the apical plasma membrane of thyroid epithelial cells, where it becomes iodinated by thyroperoxidase and where thyroid hormone formation by intramolecular coupling of iodinated thyronine residues occurs. After exocytosis, Tg is stored within the extracellular lumen of thyroid follicles in a covalently cross-linked form. The molecular nature of intermolecular covalent cross-linkage of Tg appears to be speciesspecific. Human Tg globules consist of Tg mainly cross-linked by disulfide bridges (4, 5) . In addition to disulfide cross-links, isodipeptide bonds were detected in bovine (3, 6) , and dityrosine links in porcine Tg globules (31) . Here, we have observed the occurrence of multilayered Tg in mouse thyroids, indicating that covalently cross-linked Tg exists also in the lumen of mouse thyroid follicles (Figure 8 ). However, no information exists on the nature of cross-linkages in mouse Tg globules. Therefore, further studies are needed to establish an isolation procedure that would then allow, by biochemical and biophysical means (32), a more detailed characterization of mouse Tg globules.
Because globules consisting of covalently cross-linked Tg reach dimensions of up to 120 µm in diameter, proteolysis is a necessary prerequisite for solubilization of Tg from the globules and must precede its endocytosis by thyroid epithelial cells, i.e., the recapturing pathway of Tg. First, extracellularly stored Tg undergoes limited proteolysis, leading to its solubilization from the storage forms and to T 4 liberation; then Tg becomes internalized and reaches endosomes and lysosomes for complete degradation (for review, see ref.
2).
Recently, we proposed that cycles of Tg deposition and Tg proteolysis regulate the size of the luminal content of thyroid follicles and might also explain the multilayered appearance of luminal Tg (2, (8) (9) (10) . In the present study, we have shown that Tg depositions within the lumina of thyroid follicles of cathepsin B -/-, L -/-,
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The B -/-/K -/-, or K -/-/L -/-mice lacked the typical multilayered appearance, whereas the luminal content of cathepsin K -/-mice was indistinguishable from that of WT mice. These results support the conclusion that cathepsin K is not involved in the first step of Tg proteolysis, i.e., that it is dispensable for proteolytic solubilization of Tg from covalently cross-linked Tg-globules; whereas both cathepsins B and L need to be present for proper Tg solubilization ( Figure 9 ). If Tg solubilization were impaired in the absence of cathepsin B or L, and Tg synthesis, secretion, and covalent cross-linking were unaffected, then the amounts of luminal Tg would constantly increase, because Tg could no longer become efficiently removed from the lumen. Indeed, the amounts of Tg were increased within thyroids of cathepsin
The most extreme accumulation of Tg was observed in thyroids of cathepsin B -/-mice. These mice were also characterized by the largest follicles. Possibly, the extremely thin epithelia of cathepsin B -/-thyroids were unable to resist the expansion forces of very high amounts of Tg secreted into the lumen. As a result, the volumes of cathepsin B -/-thyroids were twofold higher than those of the WTs (results not shown).
Tg solubilization is, however, not the ultimate prerequisite for efficient T 4 liberation, since serum T 4 levels were reduced in cathepsin
Hence, the amount of Tg present under conditions of impaired solubilization from its covalently cross-linked storage form due to cathepsin B deficiency is still sufficient for T 4 liberation, supporting the notion that newly synthesized Tg can become utilized directly, i.e., without being stored in covalently cross-linked Tg globules.
Thyroid function depends on the presence of cathepsins K and L. Because T 4 is the main hormone released from the thyroid gland (29) , the proteolytic step leading to the liberation of T 4 from its prohormone Tg is most important for the maintenance of thyroid function. Here, we have observed that serum T 4 levels were significantly reduced in cathepsin L -/-and K -/-/L -/-mice. The normal serum T 4 levels in cathepsin K-and B/K-deficient mice might be explained by the observation that cathepsin L expression was upregulated in thyroid epithelial cells of these mice, supporting the conclusion that cathepsin L is able to compensate for proteolytic activity of cathepsin K. Deficiencies in both proteases, cathepsins K and L, resulted in a systemically established phenotype in that serum T 4 levels were significantly reduced in cathepsin K -/-/L -/-mice when compared with the WTs, suggesting that the utilization of Tg for the liberation of T 4 is mediated by a combinatory action of cathepsins K and L (Figure 9 ).
Because serum T 4 levels were clearly reduced but T 4 was still present in the blood of mice with deficiencies in cathepsins K and L, it can be concluded that other proteases besides these two are involved in T 4 liberation from Tg. The lysosomal aspartic protease cathepsin D is an enzyme to consider in this respect, because it is known to contribute to Tg degradation (11, 28 (11), it is unlikely that cathepsin D is coresponsible for T 4 liberation in the mouse thyroid.
Besides aminopeptidase N (CD13) and dipeptidylpeptidase IV (CD26), two integral membrane proteins at the apical surface of thyrocytes whose active domains face toward the lumen of thyroid follicles (33, 34) , another enzyme that might well contribute to T 4 liberation is cathepsin S. Interestingly, the expression of cathepsin S, a member of the still growing cysteine proteinase family, is upregulated in a TSH-dependent fashion in a thyroid epithelial cell line derived from rats, FRTL-5 cells (35) . In addition, cathepsin S cleaves its substrates at neutral to slightly acidic pH conditions, and it is able to degrade Tg while liberating T 4 from its prohormone under conditions simulating the lumen of thyroid follicles (36) . Hence, cathepsin S and
Figure 9
Schematic drawing of the proposed sequence of proteolytic events leading to Tg degradation in mouse thyroid. Solubilization of extracellularly stored Tg from covalently cross-linked globules is mediated by cathepsins B and L. Soluble Tg is then subjected to limited proteolysis mediated by cathepsins K and L for Tg utilization, i.e., extracellular T 4 liberation. Thereafter, partially degraded Tg reenters thyroid epithelial cells by endocytosis and reaches endosomes and lysosomes for its complete degradation by the action of several lysosomal enzymes.
the above-mentioned exopeptidases at the apical plasma membrane of thyroid epithelial cells are promising candidates for further analysis of extracellular proteolysis of Tg leading to T 4 liberation in the thyroid.
From a systemic defect in the body's supply with thyroid hormones, one would expect further alterations to become obvious. Indeed, thyroid follicle dimensions of cathepsin K -/-/L -/-mice were increased by a factor of about two over those of the WT controls. The extension of thyroid follicles of cathepsin K -/-/L -/-mice was more pronounced than that observed in the other genotypes, except for cathepsin B -/-mice, indicating that in addition to an enlargement due to impaired Tg solubilization from its storage form, the reduced serum T 4 levels of cathepsin K -/-/L -/-mice resulted in a further enlargement of thyroid follicles. Reduced serum T 4 levels and extended thyroid follicles of cathepsin K -/-/L -/-mice are reminiscent of phenotypic alterations that indicate hypothyroidism.
Cathepsins and cell death. Despite their enlarged thyroid follicles, cathepsin K -/-/L -/-mice did not develop goiter, since the volumes of their thyroid glands were comparable to those of WT (results not shown). This might be due to the increased number of remnants of dead cells within cathepsin K -/-/L -/-follicles. Similar inclusions of dead cells were abundant in the lumina of thyroid follicles of cathepsin L -/-mice, but generally lacking from thyroids of WT or cathepsin B -/-, K -/-, or B -/-/K -/-mice, which led us to the conclusion that cathepsin L is needed for survival of thyroid epithelial cells.
A direct contribution of cysteine proteinases to the control of tissue homeostasis has been proven for cathepsin B (15) . In TNF-α-treated hepatocytes, cathepsin B was released from the lysosomes into the cytosol, where it enhanced apoptosis by mediating the release of mitochondrial cytochrome c, leading to the activation of caspases. Hence, cathepsin B promoted TNF-α-induced apoptosis of hepatocytes. It is unclear whether thyroid epithelial cells of cathepsin L -/-or K -/-/L -/-mice undergo apoptosis or necrosis. Further studies are needed to clarify this issue.
Cathepsin L has been shown to control epidermal cell proliferation (18, 19) in the stratified epithelium of the skin, i.e., epidermis. However, in cathepsin L -/-mice, the increased cell death observed in the thyroid contrasted with the hyperproliferation of basal keratinocytes observed in the epidermis of the same mice. Obviously, cathepsin L deficiency affects proliferation, differentiation, and cell death of epithelial cells of various organs differently. The notion of such diverse effects achieved under conditions of cathepsin L deficiency is further supported by a study in which cathepsin L function was analyzed in Caenorhabditis elegans by RNAi technology (37) . In C. elegans, cathepsin L deficiency resulted in slower rates of cell divisions; hence, proliferation was reduced and led to delayed growth of both larvae and worms.
So far, the precise molecular mechanisms underlying cathepsin L-mediated control of cell proliferation are unknown (18, 37) . However, the contrary effects of cathepsin L deficiency on epidermal keratinocytes (18, 19) and on thyrocytes (this study) might indicate that, in mice, growth factors or their receptors are modulated by cathepsin L-mediated proteolytic processing in a cell type-specific manner.
The results of this study support the notion that cathepsin L, together with cathepsin K, mediates thyroid hormone liberation. Hence, cysteine proteinases are not only relevant to the maintenance of tissue homeostasis but are also of significant importance for proper thyroid function.
Possible relevance of cathepsins to thyroid functions in humans. Cathepsins B, K, and L are expressed in the thyroid of all species analyzed so far, including humans (2, 8) . Therefore, the question arises as to whether thyroid functions of cathepsins are comparable in mice and humans. Results achieved by using the mouse system might even contribute to a better understanding of molecular mechanisms that lead to the onset of human disorders. In particular, the cathepsin K-deficient mouse has already proved to be a valuable animal model for the human disorder pyknodysostosis, and, hence, the understanding of cathepsin K's function in bone matrix degradation might have important implications for the treatment of osteoporosis (16, 17, 38) .
Because the maintenance of constant levels of thyroid hormones is essential for proper development and growth of mice and humans, it is possible that molecular mechanisms leading to Tg degradation and thyroid hormone liberation, similar to those described in this study for mice, also exist in humans. Support for this hypothesis comes from observations of a pathological situation of hyperthyroidism in humans, in which an upregulation of cathepsin B was detected that correlated with its increased occurrence at the apical plasma membrane of thyroid epithelial cells and, interestingly, with enhanced serum levels of thyroid hormones (39) . This observation supports our proposal that lysosomal cysteine proteinases of the normal thyroid are involved in extracellular Tg proteolysis at the apical surface of thyroid epithelial cells ( Figure 9 ) (for review, see ref.
2). In addition, the detection of increased amounts of apically located cathepsin B in hyperthyroidism in humans is in agreement with our findings in the mouse system; that is, cathepsin B was detected in association with the apical surface of WT thyrocytes of the mouse, and Tg degradation was clearly impaired when cathepsin B was lacking. Therefore, it can be concluded that at least cathepsin B is important for the degradation of Tg in both humans and mice. Consequently, it might be assumed that the expression and localization of cathepsins K and L are altered during hypo-and/or hyperthyroidism in humans. Hence, future studies must further elucidate the relevance of cathepsins for thyroid functions in humans.
